Large subretinal hemorrhage after intravitreal bevacizumab (Avastin®) for age-related macular degeneration

被引：11
|
作者：
Chieh, Janet J.
Fekrat, Sharon
机构：
[1] Duke Univ, Ctr Eye, Durham, NC 27710 USA
[2] Duke Univ, Ctr Med, Dept Ophthalmol, Durham, NC 27710 USA
来源：
ANNALS OF OPHTHALMOLOGY | 2007年 / 39卷 / 01期
关键词：
D O I：
10.1007/BF02697326
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
We report the development of a large subretinal hemorrhage 4 weeks after intravitreal bevacizumab in an 84-year-old male with 20/70 visual acuity caused by occult choroidal neovascularization from neovascular age-related macular degeneration in one eye that was treated with 1.25 mg of intravitreal bevacizumab.
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [1] Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
    Avery, RL
    Pieramici, DJ
    Rabena, MD
    Castellarin, AA
    Nasir, MA
    Giust, MJ
    OPHTHALMOLOGY, 2006, 113 (03) : 363 - 372
  • [2] Intravitreal bevacizumab (avastin) for subfoveal neovascular age-related macular degeneration
    Levy J.
    Shneck M.
    Rosen S.
    Klemperer I.
    Rand D.
    Weinstein O.
    Pitchkhadze A.
    Belfair N.
    Lifshitz T.
    International Ophthalmology, 2009, 29 (5) : 349 - 357
  • [3] Systemic and intravitreal Bevacizumab (Avastin®) in neovascular age-related macular degeneration
    Michels, S.
    Prager, F.
    Geitzenauer, W.
    Lackner, B.
    Sacu, S.
    Weigert, G.
    Kriechbaum, K.
    Polak, K.
    Georgopoulos, M.
    Schmidt-Erfurth, U.
    SPEKTRUM DER AUGENHEILKUNDE, 2007, 21 (03) : 154 - 159
  • [4] Intravitreal bevacizumab (avastin) treatment of neovascular age-related macular degeneration
    Emerson, M. Vaughn
    Lauer, Andreas K.
    Flaxel, Christina J.
    Wilson, David J.
    Francis, Peter J.
    Stout, J. Timothy
    Emerson, Geoffrey G.
    Schlesinger, Thomas K.
    Nolte, Susan K.
    Klein, Michael L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (04): : 439 - 444
  • [5] Intravitreal bevacizumab (avastin) in treatment of neovascular age-related macular degeneration
    Lazic, Ratimir
    Gabric, Nikica
    Dekaris, Iva
    Saric, Borna
    Gavric, Morena
    COLLEGIUM ANTROPOLOGICUM, 2007, 31 : 77 - 81
  • [6] Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of literature
    S Jyothi
    H Chowdhury
    M Elagouz
    S Sivaprasad
    Eye, 2010, 24 : 816 - 824
  • [7] Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration
    S. Aisenbrey
    F. Ziemssen
    M. Völker
    F. Gelisken
    P. Szurman
    G. Jaissle
    S. Grisanti
    K. U. Bartz-Schmidt
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2006, 245 : 941 - 948
  • [8] Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration
    Aisenbrey, S.
    Ziemssen, F.
    Voelker, M.
    Gelisken, F.
    Szurman, P.
    Jaissle, G.
    Grisanti, S.
    Bartz-Schmidt, K. U.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (07) : 941 - 948
  • [9] Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of literature
    Jyothi, S.
    Chowdhury, H.
    Elagouz, M.
    Sivaprasad, S.
    EYE, 2010, 24 (05) : 816 - 824
  • [10] Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage
    Stifter, Eva
    Michels, Stephan
    Prager, Franz
    Georgopoulos, Michael
    Polak, Kaija
    Hirn, Cornelia
    Schmidt-Erfurth, Ursula
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (06) : 886 - 892
12345